Orshe

Also: NEJM editors say Meridia should be yanked; stem cell plaintiffs explain themselves to the WSJ; are hospital profits the driver of health-care costs?

See the rest here: A.M. Vitals: Allergan Will Settle Off-Label Botox Allegations

Some 16 people are expected to enroll in Medicaid due to health-care overhaul legislation.

Read the rest here: New Medicaid Enrollees Likely to Be Healthier Than Current Ones: Study

Also: AARP reports on brand-name drug prices; Medtronic gives grim view of medical device demand; report says millions of older Americans may need to switch Medicare drug plans in 2011.

View original here:  A.M. Vitals: NIH to Freeze Grants for Embryonic Stem Cell Research

Strategies employers use to keep a lid on costs include cost-sharing, consumer-directed health plans and wellness programs.

Read the original post: Big Employers Estimate Health-Care Costs Will Rise 8.9% in 2011

Also: the global cost of cancer; surgery for type 2 diabetics; people are cutting back on routine medical care; complementary therapies for kids with chronic diseases.

Read the original here:  A.M. Vitals: Buffett’s Berkshire Hathaway Raises Johnson & Johnson Stake

Global health and cancer-care luminaries call for increased attention to cancer in lower-income countries.

See more here: Lance Armstrong, Sanjay Gupta Call for Focus on Cancer in Poorer Countries

Also: Will accountable care organizations save money?; pharma lobbyists may have to face Republican Congress; research shows disparities in girls’ BMI rates.

View original post here:  A.M. Vitals: FDA Approves Ella, a Longer-Acting ‘Morning-After’ Pill

It’s well-nigh impossible to conduct the type of study that would settle this question.

Here is the original: Follow-Up: Anesthesiologists, Nurse Anesthetists and Evidence

Programs limited to health assessments and “let’s get fit!” web-based efforts are most likely to fail.

Original post:  Wellness Programs Won’t Necessarily Improve Health Or Lower Costs

Also: new painkiller policy proposed in Washington State; the insured seem to be using less health care; Dendreon publishes results in the NEJM.

Excerpt from:  A.M. Vitals: Sanofi Likely to Formally Offer to Buy Genzyme